The Global Nephrology and Urology Devices Market was valued at USD 32.71 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 4.5% over the forecast period 2023-2032. The market for nephrology and urology devices is primarily driven by the increasing prevalence of chronic kidney disease (CKD) and end-stage renal disease (ESRD). According to the Centers for Disease Control and Prevention (CDC), chronic kidney disease is slightly more prevalent in women (14%) compared to men (12%). Consequently, the growing incidence of kidney diseases and other urological conditions has increased the demand for nephrology and urology devices, thereby propelling market growth during the forecast period. Additionally, increased awareness of the importance of early diagnosis and treatment of kidney and urology disorders has led to higher demand for screening and diagnostic devices, further driving the nephrology devices market growth. The American Kidney Fund supports policies to expand the use of chronic kidney disease screening and improve clinical research, provider training, and diagnosis and prevention of rare kidney diseases. Furthermore, the increasing demand for home-based dialysis solutions and portable devices provides a lucrative opportunity for the nephrology and urology devices market growth.
The rise in the incidence of conditions such as chronic kidney disease, kidney stones, urinary incontinence, and urological cancers has created a high demand for devices and treatments in nephrology and urology. This trend drives market growth during the nephrology and urology devices market analysis period. Furthermore, ongoing innovations in medical devices, such as minimally invasive surgical instruments, robotic-assisted surgeries, and improved diagnostic tools, have enhanced patient outcomes and boosted market growth. For example, Fresenius Medical Care's 6008 Series Hemodialysis Machines offer advanced features for precise dialysis treatment, enhancing the overall dialysis experience for both patients and healthcare providers. These advancements have fueled the growth of the nephrology and urology devices market. However, the high cost of urology devices negatively impacts market growth, particularly in price-sensitive regions such as Asia-Pacific. The high cost of urology endoscopes and endovision systems may hamper market growth. In addition, the lack of skilled professionals to operate and maintain urology devices is a significant factor that may restrain market growth.
The key regions considered for the Global Nephrology and Urology Devices Market study include North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominates the market in 2023 in terms of revenue. This is primarily due to its advanced healthcare infrastructure, high prevalence of kidney and urinary tract diseases, and significant investment in research and development. The region's well-established healthcare facilities and the availability of skilled healthcare professionals drive the demand for innovative nephrology and urology devices. The United States, in particular, leads the market with its high incidence of chronic kidney disease (CKD) and urological disorders, necessitating advanced treatment options. Additionally, favorable reimbursement policies and strong support from government and private healthcare organizations boost market growth. The presence of major medical device manufacturers and continuous technological advancements further enhance the region's market dominance. Increasing awareness about early diagnosis and treatment of kidney and urinary conditions, along with a growing aging population, also contribute to the rising demand for nephrology and urology devices in North America. Furthermore, Asia Pacific is projected to grow significantly during the forecast period 2024-2032.
Major market players included in this report are:
Medtronic plc
Boston Scientific Corporation
B. Braun SE
Baxter International Inc.
Coloplast
Olympus Corporation
Stryker Corporation
Teleflex Incorporated
Becton, Dickinson and Company
Karl Storz GmbH & Co. KG
STERIS
Advin Health Care
Narang Medical Limited
The detailed segments and sub-segment of the market are explained below:
By Product:
Instruments
Consumables & Accessories
By Application:
Kidney Diseases
Urological Cancer & BPH
Others
By End User:
Hospitals
Dialysis Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa
Years considered for the study are as follows:
Historical year - 2022
Base year - 2023
Forecast period - 2024 to 2032
Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market.